Deputy Director Zhou Linand his delegationvisitedLifi’s innovative manufacturing facility for in vitro diagnostic medical devices and itsproductionworkshops,and learned in detail about Lifi Biotech’s development,research achievements, market expansion, and other areas.General Manager Huang Ning provided a detailed briefing on the overall development and operation of Qingdao’s proof-of-concept platform for the commercialization of in vitro diagnostic medical device achievements, and introducedthe platform’stechnology achievement evaluation, further development, pilot-scale validation, performance testing, and mass production—the full range of proof-of-concept services—as well asproof-of-concept project cases delivered by the platform for universities, research institutes, medical institutions, and domestic and international biopharmaceutical companies.

Deputy Director Zhou Lin spoke highly of the results achieved by the proof-of-concept platform. He noted that proof of concept is a critical step in bringing scientific and technological achievements to industrialization, and encouraged Lifi Biotech to fully leverage the platform’s strengths, continuously improve its service system,precisely address the innovation needs of universities, research institutes, and enterprises,and accelerate the commercialization and application of scientific and technological achievements.

Lifi Biotech will take this visit as an opportunity to strictly implement all requirements for platform development, continuously strengthen its technological innovation capabilities, deliver comprehensive proof-of-concept services across the entire chain, deepen collaborative innovation across the industry chain, and accelerate the commercialization of more high-quality research achievements,contributing to the development of Qingdao’s biopharmaceutical industry.